(Q40008598)

16 September 2017

title

Urinary proteome analysis for prostate cancer diagnosis: cost-effective application in routine clinical practice in Germany (English)

1 reference

16 September 2017

0 references

1 reference

1 reference

Eric Schiffer

1

1 reference

16 September 2017

Carsten Bick

2

1 reference

16 September 2017

Branko Grizelj

3

1 reference

16 September 2017

Stephan Pietzker

4

1 reference

16 September 2017

Wolfgang Schöfer

5

1 reference

16 September 2017

publication date

22 November 2011

1 reference

International Journal of Urology

16 September 2017

published in

1 reference

16 September 2017

volume

19

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

118-125

1 reference

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

Discovery and validation of urinary biomarkers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02901.X

10.1111/J.1442-2042.2011.02901.X

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference